Lipe & Dalton - ADVERUM BIOTECHNOLOGIES INC ownership

Quarter-by-quarter ownership
Lipe & Dalton ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$22
-8.3%
15,0000.0%0.01%
-7.1%
Q2 2023$24
+118.2%
15,0000.0%0.01%
+133.3%
Q1 2023$11
+22.2%
15,0000.0%0.01%
+20.0%
Q4 2022$9
-99.9%
15,0000.0%0.01%
-44.4%
Q3 2022$14,000
-22.2%
15,0000.0%0.01%
-18.2%
Q2 2022$18,000
-10.0%
15,0000.0%0.01%
+10.0%
Q1 2022$20,000
-23.1%
15,0000.0%0.01%
-16.7%
Q4 2021$26,000
-21.2%
15,0000.0%0.01%
-29.4%
Q3 2021$33,000
-36.5%
15,0000.0%0.02%
-37.0%
Q2 2021$52,00015,0000.03%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 6,552,068$14,218,0008.03%
Versant Venture Management, LLC 5,068,233$10,998,0004.55%
K2 PRINCIPAL FUND, L.P. 1,653,874$3,589,0000.29%
RTW INVESTMENTS, LP 7,483,757$16,240,0000.24%
Avoro Capital Advisors LLC 6,950,000$15,082,0000.24%
Artal Group S.A. 3,000,000$6,510,0000.15%
ALGERT GLOBAL LLC 231,490$502,0000.07%
Virtus ETF Advisers LLC 57,768$125,0000.06%
Pinz Capital Management, LP 53,600$116,0000.05%
TWIN FOCUS CAPITAL PARTNERS, LLC 100,000$217,0000.05%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders